Watch the ASCO 2023 Annual Meeting Patient Forum Featured Health Equity Article Lung Cancer Screening: Implementation Challenges and Health Equity Considerations for the Western Pacific Region As part of the Special Series “Cancer Care in the Asia Pacific,” this article explores the challenges to implementing lung cancer screening in the Western Pacific Region. By Claire Nightingale et…
The American Society of Clinical Oncology (ASCO) announced four additional medical schools have been selected to participate in the Society’s Oncology Summer Internship (OSI) Program.
With improved survival benefits with ICIs and targeted therapies in metastatic NSCLC, the use of these agents has made its way into early-stage NSCLC.
An Education Session during ASCO24 will help oncologists foster deeper understanding of the needs of patients and caregivers, especially those from historically marginalized communities.
A joint International Society of Oral Oncology-Multinational Association for Supportive Care in Cancer and ASCO guideline seeks to fill a gap in the clinical guidance…
Data from a single-arm phase 2 trial conducted in China showed that glecirasib produced a response rate of 48% in patients with advanced KRASG12C-mutated NSCLC…
Learn more about the faculty and program for the Monthly Plenary Series session.
ASCO’s new policy statement on SDOH supports practices that sustain and advance cancer health equity.
Doctors Vamsi Velcheti, Sandip Patel, and Michael Zervos discuss recent updates on the management of early-stage non-small cell lung cancer (NSCLC), including the optimization of…
